Today: 18 March 2026
Barclays share price edges up as £500m buyback ends and BoE rate call nears
4 February 2026
1 min read

Barclays share price edges up as £500m buyback ends and BoE rate call nears

London, Feb 4, 2026, 08:32 GMT — Regular session

  • Shares of Barclays edged up roughly 0.3% in early London trading. The bank is set to release its full-year results on Feb. 10.
  • The bank has wrapped up a share buyback totaling about £500 million, cancelling over 107 million shares in the process
  • Investors are focused on the Bank of England’s Feb. 5 rate decision, seeking hints about where borrowing costs might head next

Barclays shares (BARC.L) rose 0.34% to 503.3 pence by 0810 GMT on Wednesday. Traders are gearing up for the bank’s full-year results, due Feb. 10. Investors Chronicle

The stock stayed steady ahead of a packed week for UK rates following Barclays’ completion of a £500 million share buyback, which will reduce its share count. Buybacks occur when a company repurchases its own stock, usually to cut the number of shares outstanding and boost earnings per share.

Barclays confirmed on Monday that it wrapped up the buyback programme announced on Oct. 23, 2025. On Jan. 30, it purchased 1,932,579 shares for cancellation at a volume-weighted average price of 487.5669 pence. The total repurchased shares reached 107,319,865, costing roughly £500 million, according to the filing. Investegate

Barclays reported in a separate statement that as of Jan. 31, it had 13,815,647,298 ordinary shares with voting rights outstanding, and no shares were held in treasury. Investegate

Rate expectations remain subdued as the Bank of England’s Monetary Policy Committee prepares to release its latest decision on Thursday. The Bank Rate stands at 3.75%, per the central bank’s calendar. Bank of England

According to Reuters on Tuesday, the market is pricing in the BoE to keep rates steady at 3.75% this Thursday. Lee Hardman, MUFG’s senior currency analyst, told Reuters, “Markets now think the Bank of England will wait until probably the May policy meeting before cutting rates further.” Reuters

Lenders watch rates closely since shifts can alter the spread between loan earnings and deposit costs — a crucial factor for net interest income. Keeping cuts gradual helps preserve that margin but can put pressure on borrowers.

Barclays’ update on Feb. 10 comes shortly after the BoE decision, offering a snapshot of how the bank is handling margins, costs, and credit quality amid the shifting rate cycle. Investors will also be watching closely to see how the investment bank fares after a rocky start to dealmaking this year.

Still, the buyback isn’t a sure thing for the stock. If the BoE hints at quicker rate cuts or the economy falters with rising bad loans, investors could put more pressure on earnings forecasts and capital buffers.

The BoE decision on Feb. 5 comes first, with Barclays’ full-year results due on Feb. 10. These are the key near-term events poised to shift expectations for Barclays’ share price.

Stock Market Today

  • Tecnoglass (TGLS) Valuation Review Amid Mixed Share Performance and Market Signals
    March 18, 2026, 10:15 AM EDT. Tecnoglass (TGLS) has experienced mixed share performance, with a 5.49% gain over the past week contrasting against declines of 15.11% over 30 days and 13.60% year-to-date. The architectural glass company reported revenue of US$983.61 million and net income of US$159.57 million. Analysts project 7.2% annual revenue growth and margin improvement from 19.1% to 20.6% over three years. Despite a recent share price pullback to US$44.96, a fair value estimate of US$66.25 suggests 32.1% upside, highlighting potential undervaluation. However, pressures like rising aluminum costs and currency strength pose risks. The current P/E ratio of 12.6x trails industry and peer averages, signaling mixed market sentiment and valuation uncertainty moving forward.
Shell stock jumps after Brazil Orca stake sale, with Q4 results next in focus
Previous Story

Shell stock jumps after Brazil Orca stake sale, with Q4 results next in focus

GSK beats 2025 sales targets — but new CEO warns 2026 growth will cool
Next Story

GSK beats 2025 sales targets — but new CEO warns 2026 growth will cool

Go toTop